HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takahashi, A. Articles by Hearse, D. J. Search for Related Content PubMed PubMed Citation Articles by Takahashi, A. Articles by Hearse, D. J.

European Journal of Cardio-Thoracic Surgery, Vol 3, 130-133, Copyright © 1989 by European Association for Cardio-thoracic Surgery

ARTICLES

Cardioplegia: relation of myocardial protection to infusion volume and duration

A Takahashi, DJ Chambers, MV Braimbridge and DJ Hearse
Cardiovascular Research, Rayne Institute, St. Thomas' Hospital, London, UK.

Clinically, initial infusion volumes of crystalloid cardioplegic solution are relatively low (500-1000 ml or 2-4 ml/g myocardium) compared to those used experimentally. In particular, rat hearts (in which many clinical solutions have been developed and evaluated) commonly use 20-30 ml/g myocardium (equivalent to 5.0-7.5 l in human heart). We used the isolated working rat heart to characterise the relationships between myocardial protection and (a) infusion duration, and (b) infusion volume of St. Thomas' Hospital cardioplegic solution (STH), Hearts were aerobically perfused (20 min) and subjected to varying durations of STH infusion (0-300 s) prior to normothermic global ischaemia (30 min). During reperfusion, maximal recovery of cardiac output occurred when infusion durations exceeded 30 s and infusion volumes exceeded 5.0 ml/g myocardium. To assess infusion volume rather than duration, hearts were infused with 1.0, 1.5 or 2.0 ml of STH for 120 s. Optimal recovery of cardiac output required 2.0 ml/g myocardium for 120 s. To assess infusion duration with low infusion volumes, 2.0 ml STH/g myocardium was infused for 10, 30, 60 and 120 s; optimal recovery of cardiac output occurred with infusions of 30 s or longer. Thus, even in the rat heart, optimal protection with STH can be achieved by infusion at a volume of 2.0 ml/g myocardium for a duration of not less than 30 s, similar to that now in current clinical use.

This article has been cited by other articles:

				G. Tian, J. Shen, J. Sun, B. Xiang, G. I. Oriaku, L. Zhezong, G. Scarth, R. Somorjai, J. K. Saunders, T. A. Salerno, et al. Does simultaneous antegrade/retrograde cardioplegia improve myocardial perfusion in the areas at risk? A magnetic resonance perfusion imaging study in isolated pig hearts J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 913 - 924. [Abstract] [Full Text] [PDF]

				G. Tian, J. Shen, S. Su, J. Sun, B. Xiang, G. I. Oriaku, J. K. Saunders, T. A. Salerno, and R. Deslauriers ASSESSMENT OF RETROGRADE CARDIOPLEGIA WITH MAGNETIC RESONANCE IMAGING AND LOCALIZED 31P SPECTROSCOPY IN ISOLATED PIG HEARTS J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 109 - 116. [Abstract] [Full Text]